Medication errors remain a major source of preventable harm in healthcare systems worldwide, contributing to significant morbidity, mortality and financial burden. Evidence indicates that a substantial proportion of hospitalised patients experience harm linked to adverse events, with medication-related incidents among the most frequent contributors. These errors can arise at any stage of the medication management process, from prescribing and dispensing to administration and monitoring. Despite growing awareness and international initiatives aimed at improving patient safety, wide variation persists in how medication safety practices are implemented across healthcare systems. A coordinated response that addresses not only individual mistakes but also the organisational, technical and governance structures that shape clinical practice has therefore gained increasing attention among hospital pharmacists, healthcare leaders and policymakers.
Governance and System-Level Drivers of Error
Analysis of medication error reports across European hospital settings highlights the prominent role of system-level factors in creating conditions for harm. Deficiencies in governance structures and inconsistent application of existing legal and professional standards contribute significantly to unsafe medication practices. Errors linked to organisational failings often involve unclear allocation of responsibilities or delegation of critical tasks to staff without the necessary qualifications or authority. In such contexts, accountability is fragmented and oversight weakened, increasing the likelihood of unsafe decisions or practices going unchallenged.
Must Read: Investing in Safer Medication Pathways
Human resource constraints further exacerbate these risks. Understaffing and reliance on insufficiently trained personnel create environments where workload pressure, fatigue and time constraints become routine. These conditions undermine adherence to established procedures and increase vulnerability to error. Alongside workforce challenges, inadequate or outdated technical resources also feature prominently. Missing or poorly maintained infrastructure, limited decision support and unsafe working environments contribute to system fragility. Together, governance, staffing and technical shortcomings form latent conditions that allow errors to pass through multiple layers of defence before reaching the patient.
Individual Errors Within Complex Medication Processes
While system-level weaknesses set the stage, individual errors remain an important component of medication-related harm. Examination of reported incidents shows that most active errors occur at points of direct patient care, particularly during prescribing and administration. Slips and lapses arise from momentary failures of attention or memory, often in situations characterised by interruptions or deviations from routine. These events are typically unintentional but can have serious consequences when safeguards are insufficient.
Mistakes, by contrast, are linked to incorrect decision-making or inadequate knowledge and skills. They occur across the medication supply chain but are especially prevalent during dose calculation, order entry and administration. High-risk parenteral medicines are particularly vulnerable to such errors, reflecting the complexity of preparation and delivery. Importantly, individual performance is shaped by organisational culture and system design. Stress, multitasking and imprecise communication are not isolated personal shortcomings but predictable responses to demanding work environments. Addressing individual errors therefore requires interventions that extend beyond education alone to encompass system redesign and cultural change.
Preventive Measures and the Role of Technology
A wide range of preventive measures has been examined to mitigate medication errors, with varying levels of effectiveness. Technology-based interventions feature prominently among the most studied approaches. Computerised prescriber order entry combined with clinical decision support has demonstrated reductions in medication error rates and prevention of adverse drug events in acute care settings. Such systems can improve guideline adherence and support safer prescribing, although the effectiveness of specific alerts varies and depends on thoughtful implementation.
Automation in dispensing and administration offers additional benefits, including reductions in omitted or delayed doses, but outcomes are influenced by staffing, workflow integration and system interoperability. Closed-loop medication management systems, including smart infusion pumps, play an important role in improving the safety of intravenous medicines, although they require ongoing optimisation to minimise workarounds and alert fatigue. Beyond technology, pharmacist-led interventions and multidisciplinary medication reviews consistently reduce the risk of harm, particularly during transitions of care. Education, simulation-based training and patient engagement also contribute to safer practice, although their impact is shaped by local context and resources.
Medication errors emerge from the interaction of individual actions with broader organisational and system-level conditions. Evidence from European hospital practice underscores that governance gaps, workforce pressures and inadequate technical infrastructure are central drivers of risk. While technological solutions and targeted interventions can reduce specific types of error, their effectiveness varies and depends on integration within a coherent system-wide strategy. Strengthening governance, fostering a just safety culture and ensuring appropriate resource allocation are therefore essential complements to education and automation. Adopting a systems-oriented approach offers a more sustainable path to reducing preventable harm and improving medication safety across complex care environments.
Source: European Journal of Hospital Pharmacy
Image Credit: iStock
